EirGenix, Inc
EirGenix - Model EG62054 -Biosimilar
FromEirGenix, Inc
Product: EG62054 Biosimilar. Indication: Undisclosed. Target: Undisclosed. Status: Preclinical.
Product: EG62054 Biosimilar. Indication: Undisclosed. Target: Undisclosed. Status: Preclinical.